Healthcare - Medical - Devices - NASDAQ - US
$ 80.48
-8.92 %
$ 2.7 B
Market Cap
91.45
P/E
Price Target
Average
98.39%
Revenue Forecast
Estimate
40.76%
EBIT
Estimate
--117.44%
Net Income
Estimate
60.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
TransMedics Group, Inc.
Wall Street analysts predict an average 1-year price target for TMDX of $160 , with forecasts ranging from a low of $109 to a high of $208 .
TMDX Lowest Price Target
Wall Street Target
109 USD
35.44%
TMDX Average Price Target
Wall Street Target
160 USD
98.39%
TMDX Highest Price Target
Wall Street Target
208 USD
158.45%
REVENUE FORECAST
Revenue Forecast Chart TMDX
EBIT FORECAST
EBIT Forecast Chart TMDX
NET INCOME FORECAST
Net Income Chart TMDX